Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1640-1652
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1640
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1640
Table 3 Updated evaluation of curability after endoscopic submucosal dissection in Japanese gastric cancer treatment guidelines 2018
| Updated evaluation of curability after endoscopic submucosal dissection | |
| eCuraA | En-bloc resection, predominantly differentiated adenocarcinoma, pathological mucosal cancer (pT1a), HM0, VM0, Ly0, V0 |
| UL0 (regardless of size) | |
| UL1, under 3 cm in diameter | |
| If size of undifferentiated component is > 2 cm, tumor is diagnosed as eCuraC-2 | |
| eCuraB | En-bloc resection, HM0, VM0, Ly0, V0 |
| UL0, under 2 cm in diameter, predominantly undifferentiated adenocarcinoma, pathological mucosal cancer (pT1a) | |
| UL1, under 3 cm in diameter, predominantly differentiated adenocarcinoma, pathological submucosal cancer within 500 µm (pT1b1) | |
| If there is an undifferentiated component in the submucosal layer, tumor is diagnosed as eCuraC-2 | |
| eCuraC-1 | Lesion meeting criteria of eCuraA or eCuraB except with positive lateral margin or non–en-bloc resection. |
| eCuraC-2 | The lesion meets none of eCuraA, eCuraB, or eCuraC-1 |
- Citation: Kinami S, Nakamura N, Tomita Y, Miyata T, Fujita H, Ueda N, Kosaka T. Precision surgical approach with lymph-node dissection in early gastric cancer. World J Gastroenterol 2019; 25(14): 1640-1652
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1640.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1640